Literature DB >> 8058633

Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro.

H E Hofland1, R van der Geest, H E Bodde, H E Junginger, J A Bouwstra.   

Abstract

The permeation of estradiol from vesicular formulations through human stratum corneum was studied in vitro. The vesicles were composed of nonionic n-alkyl polyoxyethylene ether surfactants (CnEOm). The thermodynamic activity of estradiol present in each formulation was kept constant by saturating all formulations with estradiol. The effects of both the particle size and the composition of the formulation on estradiol permeation across excised human stratum corneum were investigated. Stratum corneum that was pretreated with empty surfactant carriers allowed for significantly higher estradiol fluxes compared with untreated stratum corneum. However, estradiol fluxes obtained in these pretreatment experiments appeared to be significantly lower than those obtained by the direct application of the estradiol-saturated carrier formulation on top of the stratum corneum. Furthermore, in the case of pretreatment of the stratum corneum, an increase in carrier size resulted in a decrease in estradiol flux. For direct application the opposite was found. Two mechanisms are proposed to play an important role in vesicle-skin interactions, i.e., the penetration enhancing effect of surfactant molecules and the effect of the vesicular structures that are most likely caused by adsorption of the vesicles at the stratum corneum-suspension interface.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058633     DOI: 10.1023/a:1018963910260

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Penetration kinetics of liposomal hydrocortisone in human skin.

Authors:  W Wohlrab; J Lasch
Journal:  Dermatologica       Date:  1987

2.  Liposome-bound cortisol: a new approach to cutaneous therapy.

Authors:  J Lasch; W Wohlrab
Journal:  Biomed Biochim Acta       Date:  1986

3.  Guidelines for immunoassay data processing.

Authors:  R A Dudley; P Edwards; R P Ekins; D J Finney; I G McKenzie; G M Raab; D Rodbard; R P Rodgers
Journal:  Clin Chem       Date:  1985-08       Impact factor: 8.327

4.  Liposomes--a selective drug delivery system for the topical route of administration: gel dosage form.

Authors:  M Mezei; V Gulasekharam
Journal:  J Pharm Pharmacol       Date:  1982-07       Impact factor: 3.765

5.  Non-ionic surfactant effects on hairless mouse skin permeability characteristics.

Authors:  K A Walters; M Walker; O Olejnik
Journal:  J Pharm Pharmacol       Date:  1988-08       Impact factor: 3.765

6.  Rapid measurement of oestradiol and oestriol by high-performance liquid chromatography after automatic pretreatment.

Authors:  T Dohji; M Fushimi; T Kawabe; F Kamiyama; M Mori; N Sugita; O Tanizawa
Journal:  J Chromatogr       Date:  1984-11-28

7.  Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form.

Authors:  M Mezei; V Gulasekharam
Journal:  Life Sci       Date:  1980-05-05       Impact factor: 5.037

8.  Safety aspects of non-ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non-ionic surfactants.

Authors:  H E Hofland; J A Bouwstra; J C Verhoef; G Buckton; B Z Chowdry; M Ponec; H E Junginger
Journal:  J Pharm Pharmacol       Date:  1992-04       Impact factor: 3.765

9.  Delivery of theophylline into excised human skin from alkanoic acid solutions: a "push-pull" mechanism.

Authors:  R Kadir; D Stempler; Z Liron; S Cohen
Journal:  J Pharm Sci       Date:  1987-10       Impact factor: 3.534

10.  Interactions between liposomes and human stratum corneum in vitro: freeze fracture electron microscopical visualization and small angle X-ray scattering studies.

Authors:  H E Hofland; J A Bouwstra; H E Boddé; F Spies; H E Junginger
Journal:  Br J Dermatol       Date:  1995-06       Impact factor: 9.302

View more
  2 in total

1.  Development and optimization of novel controlled-release pioglitazone provesicular powders using 3² factorial design.

Authors:  Marwa H Shukr; Nadia A Eltablawy
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

Review 2.  Transdermal drug delivery of insulin with ultradeformable carriers.

Authors:  Gregor Cevc
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.